Alnylam Pharmaceuticals (ALNY.MX) Q3 2015 Earnings

6AugConfirmed
Q4 2014
Q1 2015
Q2 2015
Q3 2015
-13.88
-10.64
-7.41
-4.18

Details

Expected EPS
-12.0820318
Actual EPS
-13.8780095
Surprise EPS
-1.8
Surprise Percent
+14.86%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -13.8780095 per share for Q3 2015.

0 Comments

Share your thoughts